Advancing Brain Shuttle-Enabled Therapeutics for Efficient Delivery to CNS

This talk, “Advancing Brain Shuttle-Enabled Therapeutics for Efficient Delivery to CNS - Translation to Primates” was given during the 2024 Biologics conference in London, UK by Dr. Pawel Stocki - Vice President of Research at Ossianix.
In this presentation, you will learn about how Ossianix has developed the TXP1 brain shuttle based on anti-TfR1 antibody that can be fused to any therapeutic payload such as antibodies, peptide, enzymes and oligos and how this tool can overcome the brain delivery across blood-brain barrier (BBB).